What is NDC 43547-657?

43547-657 is the product NDC for Ticagrelor, Ticagrelor 90 mg/1 tablet, film coated, listed with the FDA by Solco Healthcare U.S., LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Solco Healthcare U.S., LLC, NDC labeler code 43547. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ticagrelor?

51 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ticagrelor NDC 43547-657 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)43547-657Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43547-0657Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
43547-657-06	43547065706	60 TABLET, FILM COATED in 1 BOTTLE (43547-657-06)Marketed from Apr 1, 2025
43547-657-18	43547065718	180 TABLET, FILM COATED in 1 BOTTLE (43547-657-18)Marketed from Apr 1, 2025
43547-657-50	43547065750	500 TABLET, FILM COATED in 1 BOTTLE (43547-657-50)Marketed from Apr 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ticagrelor
Generic name (nonproprietary): ticagrelor
Active ingredients: Ticagrelor — 90 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Solco Healthcare U.S., LLCNDC labeler code 43547
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208599
Marketing start: Apr 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)P2Y12 Receptor Antagonists (Mechanism)
Identifiers: Product ID 43547-657_d51fdfca-5940-4b3c-bfa2-003b208b9309SPL ID d51fdfca-5940-4b3c-bfa2-003b208b9309SPL set ID 5be5ef20-fc9f-4c3b-a482-83ffd8a3ab47RxCUI 1116635UNII GLH0314RVCUPC 0343547657062
Pharmacologic class: P2Y12 Platelet Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443547065706 followed by a unit qualifier and the quantity

Package 43547-0657-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Ticagrelor is a P2Y 12 platelet inhibitor indicated • to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. Ticagrelor tablets also reduce the risk of stent thrombosis in patients who have been stented for treatment of ACS. ( 1 .1) • to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA). ( 1.3 ) 1.1 Acute Coronary Syndrome or a History of Myocardial Infarction Ticagrelor is indicated to reduce the risk of cardiovascular (CV) deat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 43547-657

What is NDC 43547-657?: 43547-657 is the product NDC for Ticagrelor, Ticagrelor 90 mg/1 tablet, film coated, listed with the FDA by Solco Healthcare U.S., LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ticagrelor.
What is the active ingredient?: Ticagrelor.
Who is the labeler?: Solco Healthcare U.S., LLC, NDC labeler code 43547. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ticagrelor?: 51 other product NDCs are listed under this name. See all Ticagrelor NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ticagrelor NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	Laurus Labs Limited	42385-993	42385-0993-0142385-0993-0542385-0993-11+4 more
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	Laurus Labs Limited	42385-994	42385-0994-0142385-0994-0542385-0994-11+4 more
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-941	72603-0941-0172603-0941-02
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-940	72603-0940-01
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-158	11788-0158-0111788-0158-60
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-157	11788-0157-60
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	American Health Packaging	60687-935	60687-0935-21
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-047	70756-0047-60
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-048	70756-0048-6070756-0048-99
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	American Health Packaging	60687-928	60687-0928-57

All 52 Ticagrelor NDCs